Tamoxifen citrate, letrozole, anastrozole, or exemestane with or without chemotherapy in treating patients with invasive RxPONDER breast cancer

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT01272037?term=S1007&rank=1

2. Intervention

   Tamoxifen citrate

3. Intervention

   Letrozole

4. Intervention

   Systemic chemotherapy

5. Intervention

   Exemestane

6. Intervention

   Anastrozole

7. Resource Description

   This phase III clinical trial is studying how well giving tamoxifen citrate, anastrozole, letrozole, or exemestane with or without chemotherapy works in treating patients with invasive breast cancer.

8. Additional Name

   Phase III, randomized clinical trial of standard adjuvant endocrine therapy +/- chemotherapy in patients with 1-3 positive nodes, hormone receptor-positive and HER2-negative breast cancer with recurrence score (RS) of 25 or less

9. Contact

   Berenberg, Jeffrey

10. PI

    Berenberg, Jeffrey

11. Topic

    breast cancer

12. Study Population

    Females age 18 and older with histologically confirmed invasive breast cancer meeting criteria detailed on ClinicalTrials.gov.

13. Website(s)

    http://www.cancer.gov/clinicaltrials/search/view?cdrid=692475&version=healthprofessional

14. Funded by

    SWOG

15. Phase

    Phase 3 clinical trial

16. Performed by

    Clinical Protocol & Data Management Shared Resource